Latest total current liabilities for SILO: $700K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
SILO Pharma (SILO) currently reports a total current liabilities of $700K as of March 2026. That compares with $1.2M in the prior-year period — down 40.5% year over year. Use the charts on this page to explore SILO Pharma's total current liabilities history and peer comparisons.
SILO Pharma's total current liabilities decreased from $1.2M to $700K — a 40.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
SILO Pharma reported $700K in total current liabilities as of March 2026. That compares with $1.2M in the prior-year period — down 40.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $700K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SILO Pharma, and consider following SILO for alerts when major investors trade the stock.
SILO Pharma is classified in the Finance sector. On total current liabilities, it currently shows $700K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing SILO with unrelated industries.